Hepatotoxicity characterized by microvesicular steatosis (MVS) is characterized by an abnormal accumulation of numerous small cytoplasmic lipid droplets in hepatocytes. Fulminant or progressive cases of microvesicular steatosis may lead to liver failure and death. Experimentally, short-chain carboxylic acids are known to induce microvesicular steatosis. The identification of gene changes that correlate with MVS concomitant with biochemical and histological indices could provide a better understanding of how this toxicity occurs as well as biomarkers that could be used to avoid this toxicity in the future. Sprague—Dawley rats were dosed days with cyclopropane carboxylic acid (CPCA) a short-chain fatty acid that can induce microvesicular steatosis, and with butyrate, a short chain fatty acid that served as a negative control. CPCA initiated microvesicular steatosis while butyrate did not. In addition, CPCA inhibited beta-oxidation in a concentration-dependent manner in vitro and caused a reduction in mitochondrial respiration ex vivo; no inhibition was evident with butyrate. Microarray results showed that gene expression changes with CPCA resulted in regulation of genes involved in beta-oxidation, as well as other genes associated with mitochondrial function. Overall, these results support altered hepatic mitochondrial function as a mechanism of the toxicity induced by a short-chain fatty acid and may provide potential biomarkers for this toxicity.
Bulera, S.J., Eddy, S.M., Ferguson, E., Jatkoe, T.A., Reidel, J.F., Bleavins, M.R., and DeLaIglesia, F.A. (2001). RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays . Hepatology33(5), 1239—58.
2.
Burczynski, M.E., McMillian, M., Cirvo, J., Li, L., Parker, J.B., Dunn, R.T., Hicken, S., Farr, S., and Johnson, M.D. (2000). Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol Sci58, 399—415.
3.
Dahlquist, K.D., Salomonis, N., Vranizan, K., Lawlor, S.C., and Conklin, B.R. (2002). GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet31(1), 19—20.
4.
Doniger, S.W., Salomonis, N., Dahlquist, K.D., Vranizan, K., Lawlor, S.C., and Conklin, B.R. (2003). MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol4(1), R7.
5.
Elliget, K.A., and Kolaja, G.J. (1983). Preparation of primary cultures of rat hepatocytes suitable for in vitro toxicity testing. J Tissue Culture Meth8, 1—6.
6.
Hamadeh, H.K., Bushel, P.R., Jayadev, S., DiSorbo, O., Bennett, L., Li, L., Tennant, R., Stoll, R., Barrett, J.C., Paules, R.S., Blanchard, K., and Afshari, C.A. (2002). Prediction of compound signature using high density gene expression profiling. Toxicol Sci67(2), 232—40.
7.
Harries, H.M., Fletcher, S.T., Duggan, C.M., and Baker, V.A. (2001). The use of genomics technology to investigate gene expression changes in cultured human cells. Toxicol In Vitro15, 399—405.
8.
Holden, P.R., James, N.H., Brooks, A.N., Roberts, R.A., Kimber, I., and Pennie, W.D. (2000). Identification of a possible association between carbon tetrachloride-induced hepatotoxicity and interleukin-8 expression. J Biochem Mol Toxicol14(5), 283—90.
9.
Jaeschke, H., Gores, G.J., Cederbaum, A.I., Hinson, J.A., Pessayre, D., and Lemasters, J.J. (2002). Mechanisms of Hepatotoxicity. Toxicol Sci65, 166—76.
10.
Kesterson, J.W., Granneman, G.R., and Machinist, J.M. (1984). The hepatotoxicity of valproic acid and its metabolites in rats. Toxicologic, biochemical and histopathologic studies. Hepatology4(6), 1143—52.
11.
Lewis, J.H., Zimmerman, H.J., Garrett, C.T., and Rosenberg, E. (1982). Valproate-induced hepatic steatogenesis in rats . Hepatology6, 870—3.
12.
Lim, M.L., Lum, M.G., Hansen, T.M., Roucou, X., and Nagley, P. (2002). On the release of cytochrome c from mitochondria during cell death signaling. J Biomed Sci9(6 Pt1), 488—506.
13.
Losher, W., Wahnschaffe, U., Honack, D., Wittfoht, W., and Nau, H. (1992). 1992 Effects fo valproate and E-2-en-valproate on functional and morphological parameters of rat liver. Biochemical, histopathological and pharmacokinetic studies. Epilepsy Res13, 187—98.
14.
Otto, D.A., Chatzidakis, C., Kaziba, E., and Cook, G.A. (1985). Reciprocal effects of 5-(tetradecyloxy)-2-furoic acid on fatty acid oxidation. Arch Biochem Biophys242(1), 23—31.
15.
Pessayre, D., Mansouri, A., Haouzi, D., and Fromenty, B. (1999). Hepatotoxicity due to mitochondrial dysfunction . Cell Biol Toxicol15(6), 367—73.
16.
Radeva-Domuschieva, D., Maglova, L.M., Balevska, P.S., Holmuhamedov, E.L., and Evtodienko, Y.V. (1986). The influence of starvation on some characteristics of the Ca2+ transport system and lipid content in rat liver mitochondria. Acta Physiol Pharmacol Bulg12(2), 49— 54.
17.
Rehnmark, S., Giometti, C.S., Slavin, B.G., Doolittle, M.H., and Reue, K. (1998). The fatty liver dystrophy mutant mouse: microvesicular steatosis associated with altered expression levels of peroxisome proliferatorregulated proteins. J Lipid Res39, 2209—17.
Reilly, T.P., Bourdi, M., Brady, J.N., Pise-Masison, C.A., Radonovich, M.F., George, J.W., and Pohl, L.R. (2001). Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem Biophys Res Comm282, 321—8.
20.
Thomas, R.S., Rank, D.R., Penn, S.G., Zastrow, G.M., Hayes, K.R., Pande, K., Glover, E., Silander, T., Craven, M.W., Reddy, J.K., Jovanovich, S.B., and Bradfield, C.A. (2001). Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol60, 1189—94.
21.
Ulrich, R.G., Bacon, J.A., Brass, E.P., Cramer, C.T., Petrella, D.K., and Sun, E.L. (2001). Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem Biol Interact134(3), 251—70.
22.
Ulrich, R.G., Bacon, J.A., Cramer, C.T., Petrella, D.K., Sun, E.L., Meglasson, M.D., and Holmuhamedov, E. (1998). Disruption of mitochondrial activities in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxyic acid metabolite. Toxicology131(1), 33—47.
23.
Waring, J.F., Ciurlionis, R., Jolly, R.A., Heindel, M., and Ulrich, R.G. (2001a). Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity . Toxicol Lett120, 359—68.
24.
Waring, J.F., Gum, R., Morfitt, D., Jolly, R.A., Ciurlionis, R., Heindel, M., Gallenberg, L., Buratto, B., and Ulrich, R.G. (2002). Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology181—182, 537—50.
25.
Waring, J.F., Jolly, R.A., Ciurlionis, R., Lum, P.Y., Praestgaard, J.T., Morfitt, D.C., Buratto, B., Roberts, C., Schadt, E., and Ulrich, R.G. (2001b). Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol175(1), 28—42.
26.
Yang, S., Lin, H.Z., Hwang, J., Chacko, V.P., and Diehl, A.M. (2001). Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res61(13), 5016—23.
27.
Zimmerman, H.J. (1999). Hepatotoxicity. Lippincott, Williams & Wilkins, Philadelphia.
